VikramjitSinghKanwarMD

Pediatric Hematology & Oncology • Albany, NY

Pediatric Hematology-Oncology at Albany Medical Center

Join to view full profile

Dr. Kanwar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kanwar's full profile

Already have an account?

Office
47 New Scotland Ave
Albany, NY 12208
Phone+1 518-262-5513

Fax+1 518-262-5889
Is this information wrong?

Education & Training

University of TennesseeFellowship, Pediatric Hematology/Oncology, 1993 - 1996
University of California (Irvine)/Children's Hospital of Orange CountyFellowship, Pediatric Hematology/Oncology, 1991 - 1991
All India Institute of Medical SciencesClass of 1985

Certifications & Licensure

NY State Medical License 1997 - 2025
CA State Medical License 1993 - 2020
OR State Medical License 2003 - 2019
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

518 Life Magazine Castle Connolly, 2014

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Start of enrollment: 2004 Mar 15
Completed
Phase 3
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
Completed
Phase 3
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Start of enrollment: 2004 Apr 01
Active, not recruiting
Phase 3
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Start of enrollment: 2005 Nov 14
Completed
Phase 3
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor Start of enrollment: 2007 May 03
Completed
Phase 3
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Start of enrollment: 2006 Oct 30
Active, not recruiting
Phase 3
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Start of enrollment: 2006 Dec 26
Completed
Phase 3
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Start of enrollment: 2007 Mar 01
Completed
Phase 3
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Start of enrollment: 2007 Feb 26
Active, not recruiting
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Start of enrollment: 2007 Jan 22
Active, not recruiting
Phase 3
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2008 Jan 15
Active, not recruiting
Phase 3
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 May 19
Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2008 Sep 15
Recruiting
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2009 Jan 01
Completed
Phase 2
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Study of Blood Samples From Newborns With Down Syndrome Start of enrollment: 2009 Feb 23
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Start of enrollment: 2010 Jan 01
Completed
Phase 2
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Start of enrollment: 2010 Oct 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

13 citations
The role of twinning in sustainable care for children with cancer: A TIPPing point? SIOP PODC Working Group on Twinning, Collaboration, and Support.
Vikramjit S. Kanwar, Kevin R. Schwartz, Nihad Salifu, Bernard Anim, Julie Cayrol, Elizabeth Sniderman, Tim Eden> ;Pediatric Blood & Cancer. 2020 Aug 22
2 citations
Acute childhood leukemia in India: Where are we going, where have we been?
Vikramjit S. Kanwar> ;South Asian Journal of Cancer. 2016 Jul 1
42 citations
Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia
Julianne N. P. Smith, Vikramjit S. Kanwar, Katherine C. MacNamara> ;Frontiers in Immunology. 2016 Aug 29
Bone marrow transplantation for thalassemia: How much is a child's life worth?
Vikramjit S. Kanwar> ;South Asian Journal of Cancer. 2013 Oct 1
1 citations
Immunotherapy for childhood aplastic anemia in India: a case for universal healthcare?
Vikramjit S. Kanwar> ;Indian Pediatrics. 2012 May 1
Neuroblastoma obeys "The Law of Small Numbers".
Vikramjit S. Kanwar, Mary Abraham> ;Pediatric Blood & Cancer. 2012 Apr 1
2 citations
Isolated pulmonary Langerhans cell histiocytosis with recurrent bilateral pneumothoraces treated with chemotherapy and chemical pleurodesis
Lubbna Valliani, Vikramjit S. Kanwar, Adam Schwartz> ;Pediatric Blood & Cancer. 2009 Jul 15
11 citations
Sacrococcygeal immature teratoma with malignant ependymoma component.
Claudia Busse, Tipu Nazeer, Vikramjit S. Kanwar, Suzanne L. Wolden, Michael P. LaQuaglia, Marc K. Rosenblum> ;Pediatric Blood & Cancer. 2009 Oct 1
6 citations
A de novo desmoid tumor of the surgical site following foramen magnum meningioma resection in a patient with Gardner’s Syndrome: a case report and review of the litera...
Tyler J. Kenning, Vikramjit S. Kanwar, Jiang Qian, Eric M. Deshaies> ;Journal of Neuro-Oncology. 2009 Jan 1
12 citations
Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy
Vikramjit S. Kanwar, Jessica Heath, Carolyn N. Krasner, Jennifer M. Pearce> ;Pediatric Blood & Cancer. 2008 May 1
2 citations
Acute renal failure in a 17-year-old female with ALL receiving escalating intravenous methotrexate without leukovorin.
Vikramjit S. Kanwar, Jennifer M. Pearce> ;Pediatric Blood & Cancer. 2007 Aug 1
19 citations
Aluminum toxicity following intravesical alum irrigation for hemorrhagic cystitis.
Vikramjit S. Kanwar, Jesse J. Jenkins, Belinda N. Mandrell, Wayne L. Furman> ;Medical and Pediatric Oncology. 1996 Jul 1
3 citations
Magnetic resonance imaging for evaluation of childhood aplastic anemia.
Vikramjit S. Kanwar, Winfred C. Wang, H T Winer-Muram, William M. Kauffman, Suzanne A. Gronemeyer, David R. Head> ;Journal of Pediatric Hematology/oncology. 1995 Nov 1
21 citations
Veno-occlusive disease of the liver after chemotherapy for rhabdomyosarcoma: case report with a review of the literature.
Vikramjit S. Kanwar, Maria Luiza C. Albuquerque, Raul C. Ribeiro, William M. Kauffman, Wayne L. Furman> ;Medical and Pediatric Oncology. 1995 May 1
9 citations
Unusual cutaneous toxicity following treatment with dactinomycin: a report of two cases.
Vikramjit S. Kanwar, Amar J. Gajjar, Raul C. Ribeiro, Laura C. Bowman, David M. Parham, Jesse J. Jenkins> ;Medical and Pediatric Oncology. 1995 May 1
Do children need routine preoperative blood tests and blood cross matching in orthopaedic practice?
Kanwar, V. S., Mahoney, P., de la Hunt, M.> ;Ann R Coll Surg Engl. 1989 Jul
Transient erythroblastopenia of childhood associated with transient neurologic deficit: report of a case and review of the literature.
Chan, G. C., Kanwar, V. S., Wilimas, J.> ;J Paediatr Child Health. 1998 Jun
Lack of constitutive activation of Janus kinases and signal transduction and activation of transcription factors in Philadelphia chromosome-positive acute lymphoblasti...
Kanwar, V. S., Witthuhn, B., Campana, D., Ihle, J. N.> ;Blood. 1996 Jun 1
How many paediatric intensive-care beds?
Kanwar, V. S.> ;Lancet. 1993 Sep 11
Childhood cancers in India: burden, barriers, and breakthroughs.
Arora, B., Kanwar, V.> ;Indian J Cancer. 2009 Sep 15
Join now to see all

Press Mentions

Albany Med Welcomes Pediatric Cancer Specialist Dr. Kenneth LucasAugust 17th, 2017
Dancing in the Woods Raises More Than $500,000 for the Melodies Center for Childhood Cancer and Blood Disorders at Albany MedDecember 7th, 2015